Oak Street Health (OSH) PT Raised to $73 at Morgan Stanley
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
- J&J (JNJ) Privately Asked Rival Covid-19 Vaccine Makers to Inspect Clotting Risks, AstraZeneca (AZN) Said Yes but Pfizer (PFE) and Moderna (MRNA) Declined - Report
Morgan Stanley analyst Ricky Goldwasser raised the price target on Oak Street Health (NYSE: OSH) to $73.00 (from $64.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Chr Hansen Holding A/S (CHR:DC) (CHYHY) PT Lowered to DKK610 at UBS
- Movida Participacoes SA (MOVI3:BZ) PT Lowered to R$20 at Morgan Stanley
- Hella GmbH & Co KGaA (HLE:GR) (HLLGY) PT Lowered to EUR42 at Morgan Stanley
Create E-mail Alert Related CategoriesAnalyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!